Published on: Jul 04, 2015 at ESMO`s 17th World Congress on Gastrointestinal Cancer

Clinical outcomes and their correlation with gene expression in patients with advanced gastric cancer treated with pembrolizumab

By : ESMO`s 17th World Congress on Gastrointestinal Cancer

New data on @Merck’s pembrolizumab shows how gene-expression info might predict patient response to the drug.

Read More
SHARE